Sampling time [Design Issues]

posted by Durga – India, 2018-08-14 09:37 (2876 d 03:23 ago) – Posting: # 19167
Views: 4,927

We need to check the molecule available PK profile of drug (absorption, distribution and elimination). we need to read the guidelines how many sampling time points need to be set at different phases as per above mentioned.

you need to check the metabolite pharmacological activity (if applicable)

bases on the formulation also. it is also very important.


Edit: Full quote removed. Please delete everything from the text of the original poster which is not necessary in understanding your answer; see also this post #5. Please follow the Forum’s Policy[Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
363 visitors (0 registered, 363 guests [including 17 identified bots]).
Forum time: 13:01 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5